Bird Flu
148 Stories, most recent news story added 2 hours 45 minutes ago
News Stories
-
CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug ...
PR Newswire via Yahoo! Finance - 2 hours 45 minutes agoCEL-SCI Corporation , a late-stage oncology company and a developer of vaccines and therapeutics for the prevention and treatment of infectious diseases, announced today that it has retained the services of an international Contract Research Organization to run CEL-SCI's upcoming Phase III clinical trial in advanced primary head and neck cancer with the Company's lead product candidate ...
-
Terry Krepel: Swine Flu Scaremongering: How Many People Will WorldNetDaily Kill?
The Huffington Post - Mon Nov 30, 11:59 pm ETIt's not often that a news organization is determined to kill off its readers, but that's what WorldNetDaily seems to be doing in its wild...
-
Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government
PR Newswire via Yahoo! Finance - Tue Dec 1, 8:00 am ETSinovac Biotech Ltd. , a leading provider of biopharmaceutical products in China, announced today that it has received its fourth purchase order for its H1N1 vaccine, PANFLU.1, from China's Ministry of Industry and Information Technology for the national purchase plan.
-
Akonni Awarded $3.2M NIH Grant to Combine Gel-drop Microarray and PCR Technology for Rapid, Low-cost Influenza Detection
Business Wire via Yahoo! Finance - Tue Dec 1, 6:00 am ETFREDERICK, Md.----Akonni Biosystems, a molecular diagnostics company focused on providing rapid and highly scalable solutions for infectious disease testing, today announced receipt of a $3.2M Phase II SBIR grant from the National Institutes of Health .
-
Visually mapping avian flu may help H1N1
UPI - Tue Nov 17, 3:48 pm ETCOLUMBUS, Ohio, Nov. 17 (UPI) -- U.S. researchers linked several powerful computer systems to analyze enormous amounts of genetic data on the H5N1 virus, also known as avian flu.
-
Sinovac Establishes Joint Venture To Expand Human-Use Vaccine Development And Manufacturing Capabilities
PharmaceuticalOnline - Mon Nov 30, 1:23 am ETSinovac Biotech Ltd. (SVA), a leading developer and provider of vaccines, announced today that it executed a joint venture (JV) agreement to establish Sinovac (Dalian) Vaccine Technology Co., Ltd. (Sinovac Dalian).
-
NanoViricides Files Quarterly Report
Business Wire via Yahoo! Finance - Mon Nov 30, 7:00 am ETWEST HAVEN, Conn.----NanoViricides, Inc. , reports that the Company has filed its quarterly report with the SEC on November 23rd.
-
Why bird flu has not caused a pandemic
Science Daily - Fri Nov 20, 11:24 pm ETBird flu viruses would have to make at least two simultaneous genetic mutations before they could be transmitted readily from human to human, according to new research.
-
Bird Flu Virus Solution Exported to Pakistan
PR.com - Sat Nov 21, 10:31 am ETFor those concerned about the much-hyped threat of Asian bird flu, there are preventative measures. Reduce the risk of contamination with one easy solution. [PR.com - July 31, 2006]
-
Bird flu human-to-human spread unlikely
UPI - Fri Nov 20, 1:56 am ETLONDON, Nov. 20 (UPI) -- Bird flu would need two simultaneous mutations to spread from human to human, British and U.S. researchers say.
-
NEWS SCAN: H5N1 transmission study, Egypt H5N1 case, Cape Verde dengue cases, Colorado Salmonella outbreak cause
Center for Infectious Disease Research and Policy - Thu Nov 19, 7:19 pm ETStudy: H5N1 needs double mutation to gain human transmissibility A team of British and American researchers say their experiments suggest that the H5N1 avian influenza virus would have to undergo at least two simultaneous mutations to gain the ability to spread easily from human to human.
-
New Research Helps Explain Why Bird Flu Has Not Caused A Pandemic
redOrbit - Thu Nov 19, 5:08 pm ETBird flu viruses would have to make at least two simultaneous genetic mutations before they could be transmitted readily from human to human, according to research published today in PLoS ONE.The authors of the new study, from Imperial College London, the University of Reading and the University of North Carolina, USA, argue that it is very unlikely that two genetic mutations would occur at the ...
-
Vaccine makers are slow to perfect new techniques
Washington Post - Tue Nov 24, 12:00 am ETAfter a lethal bird flu virus emerged in Asia, U.S. officials launched an intense effort to build new defenses against a pandemic, including replacing an antiquated vaccine system, which depends on millions of chicken eggs.
-
Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased
PRWeb via Yahoo! News - Fri Nov 27, 11:30 am ETBiotech firm Replikins Ltd. today issued its latest biochemical analysis of the H1N1 virus genomic data. It shows that the lethality of the virus has dropped from its peak of 3.7 (s.d. 4.5) during the virus's current outbreak in the spring of 2009 to resting non-epidemic levels this week of 2.0 (s.d. 0.1). The H1N1 infectivity count, however, remains increased.
-
Medicago announces 2009 third quarter financial results
CNW Group via Yahoo! Finance - Fri Nov 27, 12:00 pm ETMedicago Inc. , a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced its operational and financial results for the third quarter ended September 30, 2009.
Video
WHO: Avian Influenza Updates
-
Avian influenza - situation in Egypt - update 25
Fri Nov 27, 4:00 am EST -
Cumulative Number of Confirmed Human Cases of Avian Influenza A/(H5N1) Reported to WHO
Fri Nov 27, 3:00 am EST -
Avian influenza - situation in Egypt - update 24
Fri Nov 20, 4:00 am EST
